Asia Healthcare Analyst, Pathology Associates Limited

Dion Stéfan Büchner M.D., FCAP

Asia Healthcare Analyst

Pathology Associates Limited

Thematic (Sector/Industry)

With a focus on novel mechanisms of action (MoA), we highlight select non-Hodgkin's lymphoma (NHL) and Multiple Myeloma (MM) related abstracts at the upcoming American Society of Hematology (<a href="http://www.hematology.org/Annual-Meeting/" target="_blank">ASH – 2016</a>) conference in San Diego this weekend.We use our proprietary ranking methodology (PRM) to rank concerned abstracts on seven criteria (mechanism of action, clinical phase, indication, route of administration, study design, safety profile and efficacy profile) and assign weight to each criterion...

With a focus on novel mechanisms of action (MoA), we highlight select non-Hodgkin's lymphoma (NHL) and Multiple Myeloma (MM) related abstracts at the upcoming American Society of Hematology (ASH – 2016) conference in San Diego this weekend.We use our proprietary ranking methodology (PRM) to rank concerned abstracts on seven criteria (mechanism of action, clinical phase, indication, route of administration, study design, safety profile and efficacy profile) and assign weight to each criterion...

American Society of Hematology (ASH) -Annual Conference (2016) Preview

European Event-Driven Analyst

Jesus Rodriguez Aguilar

Event-Driven

<ul>
<li>April saw dispersion re-expand, with median and mean widening modestly, confirming no systemic repricing of voting rights but renewed divergence across liquidity- and structure-driven dual-class pairs.</li>
<li>Convergence remained selective: Grifols, MFE and Sixt tightened, while Carlsberg, Fuchs and Handelsbanken re-widened, highlighting the episodic nature of ord/pref convergence.</li>
<li>Telecom Italia transitions towards corporate-action, while Nordic anomalies—particularly Handelsbanken—continue to dominate dispersion and constrain arbitrage.</li>
</ul>


April saw dispersion re-expand, with median and mean widening modestly, confirming no systemic repricing of voting rights but renewed divergence across liquidity- and structure-driven dual-class pairs.
Convergence remained selective: Grifols, MFE and Sixt tightened, while Carlsberg, Fuchs and Handelsbanken re-widened, highlighting the episodic nature of ord/pref convergence.
Telecom Italia transitions towards corporate-action, while Nordic anomalies—particularly Handelsbanken—continue to dominate dispersion and constrain arbitrage.


Liquid Universe of European Ordinary and Preferred Shares: April '26 Report

Pharma/ Biotechnology Investments Specialist, Vasuda Capital Management

Dr. Bhavneesh Sharma, MD, MBA

Pharma/ Biotechnology Investments Specialist

Vasuda Capital Management

<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/016/178/original/download%20%281%29.jpg?1478808170" class="editor-image img-responsive" data-smartkarma-image-id="16178"></figure><div class="content-caption">(I thought it was a reality show till I was shown the Oval Office today!)</div>Now that the initial shock period is over, we return to finding out how President Trump could affect the U.S. (and with it the global) healthcare and pharmaceutical sector. Broadly, Trump's policy on healthcare has focused on two issues: allowing Medicare to negotiate drug prices directly with the drug companies and repealing Obamacare.<div class="content-highlight">Drug Pricing and Trump:</div>Allowing Medicare and similar U.S. government programs to…

(I thought it was a reality show till I was shown the Oval Office today!)Now that the initial shock period is over, we return to finding out how President Trump could affect the U.S. (and with it the global) healthcare and pharmaceutical sector. Broadly, Trump's policy on healthcare has focused on two issues: allowing Medicare to negotiate drug prices directly with the drug companies and repealing Obamacare.Drug Pricing and Trump:Allowing Medicare and similar U.S. government programs to…

President Trump and Healthcare (And Pharma) Sector: What's Next?

Bespoke Research on China and neighbouring regions, Bixmoor

Bixmoor

Bespoke Research on China and neighbouring regions

Bixmoor specialises in providing bespoke research to business, governments and the financial community on China and neighbouring regions. We seek to build long-term relationships with our clients, based on our expertise, our reliability and our determination to find the right solution.

A comprehensive world survey of population heights over the last century has thrown up some surprising results. Americans have had the smallest height gain of any developed country, whereas Koreans have grown by an average of six inches over the last 100 years.

A comprehensive world survey of population heights over the last century has thrown up some surprising results. Americans have had the smallest height gain of any developed country, whereas Koreans have grown by an average of six inches over the last 100 years. 

<ul>
<li>March saw broad-based tightening across Europe’s dual-class universe, reversing February’s dispersion widening. Both the median and mean moved towards convergence, driven by retracement in structurally wide spreads.</li>
<li>Liquidity-Driven convergence reasserted itself in Fuchs, Carlsberg, Grifols and Sixt, while Handelsbanken remained the dominant structural anomaly despite meaningful tightening.</li>
<li>Telecom Italia continues to behave as a dividend-anchored structure, but with the approved savings conversion, convergence is increasingly shaped by corporate action rather than pure market arbitrage.</li>
</ul>


March saw broad-based tightening across Europe’s dual-class universe, reversing February’s dispersion widening. Both the median and mean moved towards convergence, driven by retracement in structurally wide spreads.
Liquidity-Driven convergence reasserted itself in Fuchs, Carlsberg, Grifols and Sixt, while Handelsbanken remained the dominant structural anomaly despite meaningful tightening.
Telecom Italia continues to behave as a dividend-anchored structure, but with the approved savings conversion, convergence is increasingly shaped by corporate action rather than pure market arbitrage.


Liquid Universe of European Ordinary and Preferred Shares: March '26 Report

Spain

Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Grifols SA (GRF SM)

American Society of Hematology (ASH) -Annual Conference (2016) Preview

With a focus on novel mechanisms of action (MoA), we highlight select non-Hodgkin's lymphoma (NHL) and Multiple Myeloma (MM) related abstracts at...

Dion Stéfan Büchner M.D., FCAP

Liquid Universe of European Ordinary and Preferred Shares: April '26 Report

European dual-class spreads re-widened in April, with mean rising on right-tail moves. Liquidity-driven convergence persists, while structural...

Jesus Rodriguez Aguilar

President Trump and Healthcare (And Pharma) Sector: What's Next?

Now that the initial shock period is over, we return to finding out how President Trump could affect the U.S. (and with it the global) healthcare...

Dr. Bhavneesh Sharma, MD, MBA

A 'heads Up' on Changing World Heights

A comprehensive world survey of population heights over the last century has thrown up some surprising results. Americans have had the smallest...

Bixmoor

Liquid Universe of European Ordinary and Preferred Shares: March '26 Report

March saw convergence across European dual-class shares, with dispersion narrowing as liquidity returned. Structural outliers persist, while...

Jesus Rodriguez Aguilar

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)